Exelixis, Inc. (0IJO.L)

USD 34.24

(-1.28%)

Total Debt Summary of Exelixis, Inc.

  • Exelixis, Inc.'s latest annual total debt in 2023 was 189.94 Million USD , down -0.12% from previous year.
  • Exelixis, Inc.'s latest quarterly total debt in 2024 Q2 was 198.01 Million USD , down -1.71% from previous quarter.
  • Exelixis, Inc. reported annual total debt of 190.17 Million USD in 2022, up 270.9% from previous year.
  • Exelixis, Inc. reported annual total debt of 51.27 Million USD in 2021, up 4.45% from previous year.
  • Exelixis, Inc. reported quarterly total debt of 194.44 Million USD for 2024 Q3, down -1.8% from previous quarter.
  • Exelixis, Inc. reported quarterly total debt of 201.46 Million USD for 2024 Q1, up 6.07% from previous quarter.

Annual Total Debt Chart of Exelixis, Inc. (2023 - 1998)

Historical Annual Total Debt of Exelixis, Inc. (2023 - 1998)

Year Total Debt Total Debt Growth
2023 189.94 Million USD -0.12%
2022 190.17 Million USD 270.9%
2021 51.27 Million USD 4.45%
2020 49.08 Million USD -3.26%
2019 50.73 Million USD 316.64%
2018 12.17 Million USD -16.19%
2017 14.53 Million USD -92.32%
2016 189.12 Million USD -50.42%
2015 381.43 Million USD 5.47%
2014 361.65 Million USD 4.15%
2013 347.23 Million USD 3.43%
2012 335.73 Million USD 84.96%
2011 181.51 Million USD -12.92%
2010 208.45 Million USD 161.83%
2009 79.61 Million USD -32.34%
2008 117.68 Million USD -3.16%
2007 121.51 Million USD -0.11%
2006 121.65 Million USD -18.27%
2005 148.84 Million USD 1.01%
2004 147.35 Million USD 32.65%
2003 111.08 Million USD 50.25%
2002 73.93 Million USD 51.06%
2001 48.94 Million USD 227.38%
2000 14.95 Million USD 12.41%
1999 13.3 Million USD 0.0%
1998 - USD 0.0%

Peer Total Debt Comparison of Exelixis, Inc.

Name Total Debt Total Debt Difference
Editas Medicine, Inc. 36.53 Million USD -419.882%
Dynavax Technologies Corporation 256.91 Million USD 26.067%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -357.399%
Perrigo Company plc 4.07 Billion USD 95.337%
Illumina, Inc. 2.26 Billion USD 91.603%
Thermo Fisher Scientific Inc. 34.91 Billion USD 99.456%
Iovance Biotherapeutics, Inc. 1 Million USD -18894.4%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 98.012%
IQVIA Holdings Inc. 14.23 Billion USD 98.665%
Heron Therapeutics, Inc. 173.75 Million USD -9.318%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 92.973%
Unity Biotechnology, Inc. 26.99 Million USD -603.757%
Waters Corporation 2.35 Billion USD 91.936%
Biogen Inc. 7.33 Billion USD 97.412%
Sangamo Therapeutics, Inc. 38.1 Million USD -398.488%
Evolus, Inc. 126.54 Million USD -50.099%
Adicet Bio, Inc. 17.7 Million USD -972.948%
Cara Therapeutics, Inc. 43.16 Million USD -340.021%
bluebird bio, Inc. 330.32 Million USD 42.498%
Esperion Therapeutics, Inc. 540.94 Million USD 64.887%
FibroGen, Inc. 170.45 Million USD -11.434%
Agilent Technologies, Inc. 2.73 Billion USD 93.055%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -809.509%
Homology Medicines, Inc. 44.05 Million USD -331.162%
Geron Corporation 85.89 Million USD -121.125%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD 92.079%
Amicus Therapeutics, Inc. 445.05 Million USD 57.322%
Myriad Genetics, Inc. 145 Million USD -30.996%
Viking Therapeutics, Inc. 1.26 Million USD -14974.921%
Intellia Therapeutics, Inc. 115.34 Million USD -64.673%
Zoetis Inc. 6.8 Billion USD 97.208%
Abeona Therapeutics Inc. 4.4 Million USD -4214.948%
Mettler-Toledo International Inc. 2.16 Billion USD 91.238%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 83.248%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 76.504%
Kala Pharmaceuticals, Inc. 36.32 Million USD -422.93%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 86.932%
Atara Biotherapeutics, Inc. 57.87 Million USD -228.214%
Verastem, Inc. 41.55 Million USD -357.069%
Nektar Therapeutics 230.4 Million USD 17.559%
Axsome Therapeutics, Inc. 186.37 Million USD -1.917%
Aclaris Therapeutics, Inc. 3.07 Million USD -6079.05%
Sarepta Therapeutics, Inc. 1.39 Billion USD 86.402%
OPKO Health, Inc. 326.56 Million USD 41.836%
Neurocrine Biosciences, Inc. 428.4 Million USD 55.662%
Corcept Therapeutics Incorporated 151 Thousand USD -125690.728%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 138.4 Million USD -37.234%
Imunon, Inc. 1.13 Million USD -16572.094%
Blueprint Medicines Corporation 774.12 Million USD 75.463%
Insmed Incorporated 1.2 Billion USD 84.224%
Halozyme Therapeutics, Inc. 1.49 Billion USD 87.331%
Agios Pharmaceuticals, Inc. 56.98 Million USD -233.305%
TG Therapeutics, Inc. 110.79 Million USD -71.437%
Incyte Corporation 38.28 Million USD -396.106%
Emergent BioSolutions Inc. 877.5 Million USD 78.354%